Equity Transactions (Tables)

9 Months Ended

Mar. 31, 2019

Stockholders' Equity Note [Abstract]

Schedule for proceeds of the offering [Table Text Block]

The Company accounted for the proceeds of the Offering at February 27, 2019 as follows:

Gross proceeds	$	2,500,000
Less: Offering costs		150,000
Net proceeds		2,350,000
Portion allocated to derivative liability - warrants		(1,527,259	)
Net proceeds from issuance of common stock	$	822,741

Schedule Of Fair Value Of Stock Classified By Issuance Date [Table Text Block]

The fair value of the Series A Preferred stock was the following for the dates indicated:

Date	Shares		Value
7/11/2018		525,000	$	560,690
7/31/2018		2,572		2,795
8/31/2018		2,572		2,374
9/30/2018		2,572		2,598
10/31/2018		2,572		2,233
11/30/2018		2,572		1,883
12/31/2018		2,572		2,245
1/31/2019		2.572		1,203
2/28/2019		2,572		1,949
3/01/2019		26,786		24,340
3/31/2019		2,572		2,336
		574,934	$	604,646

Schedule of Stockholders Equity [Table Text Block]

The Company estimated the fair value of the warrants granted to the Scientific Advisory Board on the date of grant using the Black-Scholes Option-Pricing Model with the following weighted-average assumptions:

Expected life (year)	4
Expected volatility	47.99-55.12	%
Expected annual rate of quarterly dividends	0.00	%
Risk-free rate(s)	2.51-2.93	%